Jan 13, 2026
Event Recap | “Four-Chain Integration” Xiamen Biopharmaceuticals Overseas Expansion Exchange in Singapore Successfully Concluded!
Overseas expansion for biopharmaceutical companies is a systematic process driven by the coordination of the industrial, innovation, capital, and service chains, with Singapore providing a crucial strategic foothold thanks to its well-established regulatory framework and regional hub advantages.








